Table 1.
Baseline characteristics of the study cohort (n=17)
| Characteristic | Value (%) |
|---|---|
| No. of Patients | 17 (100) |
| Sex | |
| • Female | 7 (41.2) |
| • Male | 10 (58.8) |
| Age* | |
| • All patients | 64 ± 6 years |
| • Female | 64 ± 6 years |
| • Male | 64 ± 5 years |
| Risk factors | |
| Hepatitis C | 3 (17.6) |
| Cholelithiasis | 2 (11.8) |
| Alcoholic liver disease | 1 (5.9) |
| Nonalcoholic steatohepatitis | 1 (5.9) |
| Presenting symptoms | |
| Abdominal pain | 8 (47.1) |
| Weight loss | 6 (35.3) |
| Malaise | 4 (23.5) |
| Eastern Cooperative Oncology Group Performance Status | |
| • Grade 0 | 7 (41.2) |
| • Grade 1 | 10 (58.8) |
| Child-Pugh Class | |
| • A | 16 (94.1) |
| • B | 1 (5.9) |
| Biopsy proven ICC Tumor type | 17 (100) |
| • Central ICC | 3 (17.6) |
| • Peripheral ICC | 14 (82.4) |
| Number of lesions | |
| • 1 | 7 (41.2) |
| • 2–3 | 5 (29.4) |
| • 4 or more | 5 (29.4) |
| Tumor location | |
| Right lobe | 6 (35.3) |
| Left lobe | 3 (17.6) |
| Bilobar | 8 (47.1) |
| Extrahepatic disease | 2 (11.8) |
Note: Except where indicated, data represents numbers of patients and numbers in parentheses are percentages.
*
Data represented as mean ± standard deviation.